We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Rules FDA Must Grant Orphan Drug Exclusivity for Bendeka
Court Rules FDA Must Grant Orphan Drug Exclusivity for Bendeka
In a second successful legal challenge of the FDA’s approach to orphan drug designations, a federal court ordered the agency to grant Eagle Pharmaceuticals orphan drug exclusivity for its cancer drug Bendeka.